EPSRC logo

Details of Grant 

EPSRC Reference: EP/X01729X/1
Title: Targeting the infectious potential of prions with DNA nanotechnology
Principal Investigator: Serpell, Dr CJ
Other Investigators:
Xue, Dr W
Researcher Co-Investigators:
Project Partners:
Department: Sch of Physical Sciences
Organisation: University of Kent
Scheme: Standard Research - NR1
Starts: 01 December 2022 Ends: 02 July 2023 Value (£): 201,710
EPSRC Research Topic Classifications:
Synthetic biology
EPSRC Industrial Sector Classifications:
No relevance to Underpinning Sectors
Related Grants:
Panel History:
Panel DatePanel NameOutcome
21 Jun 2022 New Horizons 2021 Full Proposal Panel Announced
23 Jun 2022 New Horizons Biomedical and Chemical Engineering Panel June 2022 Announced
Summary on Grant Application Form
Amyloids are aggregates of misfolded proteins which are linked to neurodegenerative diseases, and can in some cases be infectious. The mechanistic links between amyloid structure and disease presentation are not yet understood, which means that there is an urgent need for new treatments. Understanding the relationship between their structure and biological role is challenging because it is difficult to isolate populations with single, static structures.

We present a new strategy which will enable study of the relationship between amyloid structure/polymerization state and infectivity, by putting DNA nanotechnology to work in controlling amyloid assembly. Using covalent and supramolecular interface of DNA with Sup35NM, an infective yeast amyloid-forming protein, the impact of programmed DNA hybridization upon the amyloid structure, polymorphism, and mechanical properties will be studied, enabling production of stable amyloid assemblies across a range of sizes.

The infective potential of the DNA-amyloid materials will then be studied by the expression of [PSI+] phenotype in yeast system which will give us unique and valuable new insights into the structural factors which influence amyloid infectivity, and thus assist in the understanding of neurodegenerative diseases and in production of new therapeutics.

Key Findings
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Potential use in non-academic contexts
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Impacts
Description This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Summary
Date Materialised
Sectors submitted by the Researcher
This information can now be found on Gateway to Research (GtR) http://gtr.rcuk.ac.uk
Project URL:  
Further Information:  
Organisation Website: http://www.kent.ac.uk